Atlas Venture
Atlas et al. in $30m round for Replimune
Series-A backers include Atlas Venture, Forbion and Omega Funds
VC-backed 3V sold to SafeCharge for €14.5m
Atlas Venture led €20m series-A for pre-paid charge card company in 2006
Atlas et al. invest £20m in Bicycle Therapeutics
VC firms were joined by several corporate healthcare venture arms
SmartCap et al. exit GrabCAD for reported $100m
Sale likely to be largest Estionian exit since Skype in 2011
Zoopla shares up 7% following IPO
Atlas and Octopus retain stake in UK property search website
VC-backed Zoopla formalises IPO plans
Flotation could value business at more than £1bn
Accel hires Atlas's Fred Destin as partner
Fred Destin, Accel Partners
VC-backed Egalet raises $50.4m in IPO
VC-backed UK pharma Egalet has raised $50.4m in its IPO on the Nasdaq, giving the company a market cap of $166.8m.
SEP et al. sell Zinwave to McWane
US manufacturing company McWane has acquired venture capital-backed Zinwave, a UK provider of in-building wireless coverage infrastructure.
VC-backed Egalet files $45.5m IPO
UK-based pharma company Egalet, backed by a consortium of venture capital firms, is seeking to raise up to $45.5m in its IPO on the Nasdaq.
F-star raises €9.4m from Atlas, Aescap et al.
Biopharmaceutical company F-star has raised €9.4m in a series-A round supported by Altas Venture, Aescap Venture, TVM Capital among others.
Index leads $20m Egalet round
Index Ventures has led a $20m funding round for Egalet, a pharmaceutical company specialising in the development of abuse-deterrent oral products.
Atlas leads €2.5m round for Harbour Antibodies
Atlas Venture has led a €2.5m funding round for Rotterdam-based Harbour Antibodies, an engineer of transgenic mice designed to produce high-affinity human antibodies.
Gimv et al. back Jenavalve
A consortium of venture capital investors has injected $62.5m as part of a series-C round for Jenavalve Technology, a Germany-based medical devices manufacturer.
Cisco buys venture-backed Ubiquisys for $310m
Small cells developer Ubiquisys, a portfolio company of Advent Venture Partners, Accel Partners and Atlas Venture, has been bought by US corporate Cisco for $310m.
VCs in £3.75m round for Bicycle Therapeutics
Biotherapeutics firm Bicycle Therapeutics has received £3.75m from existing and new venture capital investors.
Index Ventures leads £8m funding for Secret Escapes
Index Ventures has led an £8m funding round for UK-based online luxury travel club Secret Escapes.
Ubiquisys raises a further $19m
UK-based 3G technology company Ubiquisys has raised $19m in an oversubscribed round from existing investors, as well as new Chinese investors Mobile Internet Capital and Nissay Capital.
Notion Capital backs The Currency Cloud with £2m
Notion Capital has invested £2m in UK-based payments platform The Currency Cloud.
Atlas Venture leads $4M round for The Currency Cloud
Atlas Venture has joined existing investor Anthemis Group in a $4M series-A funding round for The Currency Cloud.
Atlas and Octopus inject £3.25m in Zoopla
Atlas Venture and Octopus Investments have provided £3.25m of new funding in property website Zoopla.co.uk.
Advent et al. exit Phyworks for $72.5m
Advent Ventures has sold fabless semiconductor company Phyworks Ltd for $72.5m to US-listed analog chip maker Maxim Integrated Products Inc.
Advent, Accel and Atlas back $9m Ubiquisys deal
Existing investors Advent Venture Partners, Accel Partners and Atlas Venture have participated in a further $9m funding round for mobile telecommunications company Ubiquisys.
Atlas Venture et al. sell shares in Priceminister
Japanese e-commerce specialist Rakuten has acquired a 100% stake in the Priceminister group from Atlas Venture, Phillimore, Technocap, Quilvest and individual shareholders.